EU Pediatric Regulation (EC 1901/2006) came into force in 2007 with the aim to improve the health of the children in Europe by increasing the research and authorization of medicines for children and improving the information on medicines designed for children. To meet the objectives of the regulation, increasing number of pediatric clinical trials needs to be conducted. This requires more research capacity; increasing demand for investigators, centres and networks in Europe.

Since 2013, the Pharma Industry Finland together with the Finnish Investigators network for Pediatric Medicines – FinPedMed - have been facilitating Academic and Pharma Industry collaboration for pediatric clinical trials in the Nordic area. This 3rd Nordic conference will bring forward ideas and solutions to facilitate medicine development for children, and updating the current information related to pediatric Clinical Trials.

Finland’s third EU Presidency of the Council of the European Union period begins on 1 July 2019 and lasts to the end of the year. The second half of 2019 will also mark the beginning of the work of the New EU Parliament and Commission. This is important moment for all stakeholders to join the debate on a joint vision about the future parameters for pediatric medicines rsearch.

The City of Helsinki has invited the participants for a Networking event to the Old City Hall.

The program. 

The registration is open